TRCT
BCPC

Tower Research Capital (TRC)’s Balchem Corp BCPC Stock Holding History

Tower Research Capital (TRC)’s Portfolio BCPC Stock Details BCPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$403K Buy
2,378
+1,510
+174% +$256K 0.01% 1075
2025
Q4 		$133K Sell
868
-391
-31% -$59.7K ﹤0.01% 1746
2025
Q3 		$189K Sell
1,259
-2,571
-67% -$405K 0.01% 1504
2025
Q2 		$610K Buy
3,830
+3,636
+1,874% +$590K 0.02% 824
2025
Q1 		$32.2K Sell
194
-401
-67% -$65.8K ﹤0.01% 2561
2024
Q4 		$97K Sell
595
-532
-47% -$92.3K ﹤0.01% 2158
2024
Q3 		$198K Sell
1,127
-4,264
-79% -$726K 0.01% 1624
2024
Q2 		$830K Buy
5,391
+5,189
+2,569% +$781K 0.01% 910
2024
Q1 		$31.3K Sell
202
-13,474
-99% -$2M ﹤0.01% 2613
2023
Q4 		$2.03M Buy
13,676
+11,551
+544% +$1.48M 0.03% 506
2023
Q3 		$264K Buy
2,125
+1,518
+250% +$202K 0.01% 1262
2023
Q2 		$81.8K Sell
607
-319
-34% -$41K ﹤0.01% 2192
2023
Q1 		$117K Buy
926
+635
+218% +$82.1K ﹤0.01% 1726
2022
Q4 		$36K Sell
291
-4,239
-94% -$560K ﹤0.01% 2597
2022
Q3 		$551K Buy
4,530
+3,492
+336% +$455K 0.01% 1067
2022
Q2 		$135K Buy
1,038
+514
+98% +$64.3K ﹤0.01% 2061
2022
Q1 		$71K Buy
524
+68
+15% +$9.74K ﹤0.01% 2451
2021
Q4 		$77K Sell
456
-2,494
-85% -$400K ﹤0.01% 2420
2021
Q3 		$428K Buy
2,950
+1,863
+171% +$252K 0.01% 1106
2021
Q2 		$143K Sell
1,087
-1,013
-48% -$130K ﹤0.01% 2156
2021
Q1 		$264K Buy
2,100
+1,031
+96% +$125K ﹤0.01% 1772
2020
Q4 		$123K Sell
1,069
-23,935
-96% -$2.53M ﹤0.01% 2154
2020
Q3 		$2.44M Buy
25,004
+22,221
+798% +$2.18M 0.03% 282
2020
Q2 		$264K Buy
+2,783
New +$260K 0.01% 1558
2020
Q1 		– Sell
-345
Closed -$35K – 4058
2019
Q4 		$35K Sell
345
-659
-66% -$66.5K ﹤0.01% 1568
2019
Q3 		$100K Buy
1,004
+353
+54% +$33.6K 0.01% 1350
2019
Q2 		$65K Buy
+651
New +$63.3K ﹤0.01% 1437
2018
Q4 		– Sell
-201
Closed -$23K – 4461
2018
Q3 		$23K Buy
+201
New +$21.1K ﹤0.01% 2262
2017
Q4 		– Sell
-3,942
Closed -$321K – 4113
2017
Q3 		$321K Buy
3,942
+3,863
+4,890% +$297K 0.03% 453
2017
Q2 		$6K Sell
79
-83
-51% -$6.62K ﹤0.01% 1927
2017
Q1 		$13K Buy
162
+86
+113% +$7.23K ﹤0.01% 1611
2016
Q4 		$6K Sell
76
-224
-75% -$17.7K ﹤0.01% 2983
2016
Q3 		$23K Sell
300
-2,277
-88% -$151K ﹤0.01% 1536
2016
Q2 		$154K Buy
+2,577
New +$158K 0.01% 836
2016
Q1 		– Sell
-301
Closed -$18K – 5074
2015
Q4 		$18K Buy
301
+228
+312% +$14.8K ﹤0.01% 1426
2015
Q3 		$4K Sell
73
-1,032
-93% -$59.8K ﹤0.01% 2998
2015
Q2 		$61K Sell
1,105
-1,643
-60% -$94.5K 0.01% 1211
2015
Q1 		$152K Buy
+2,748
New +$157K 0.02% 578
2014
Q4 		– Sell
-1,233
Closed -$70K – 4788
2014
Q3 		$70K Buy
+1,233
New +$65.7K 0.01% 1262
2014
Q2 		– Sell
-267
Closed -$14K – 4729
2014
Q1 		$14K Sell
267
-1,467
-85% -$78.8K ﹤0.01% 2278
2013
Q4 		$102K Sell
1,734
-98
-5% -$5.53K 0.02% 857
2013
Q3 		$95K Buy
1,832
+1,532
+511% +$75.5K 0.01% 1350
2013
Q2 		$13K Buy
+300
New +$13.4K ﹤0.01% 2141

Other funds holding BCPC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tower Research Capital (TRC)'s BCPC Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Balchem Corp (BCPC) stake by 174% in Q1 2026, buying an estimated $256K and bringing the position to 2,378 shares worth $403K. The position accounts for 0.01% of the portfolio, ranked #1075.

Tower Research Capital (TRC) first reported a position in BCPC in Q2 2013 and has held it in 43 quarters since. The position peaked at $2.44M in Q3 2020. 422 funds tracked by Wall St. Rank hold BCPC as of Q1 2026.

  • Tower Research Capital (TRC) held 2,378 shares of Balchem Corp worth $403K as of Q1 2026.
  • Tower Research Capital (TRC) bought 1,510 Balchem Corp shares in Q1 2026, an estimated $256K.
  • Balchem Corp made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1075 holding.
  • Tower Research Capital (TRC) first reported a position in Balchem Corp in Q2 2013 and has held it in 43 quarters since.
  • Tower Research Capital (TRC)'s Balchem Corp position peaked at $2.44M in Q3 2020.
  • 422 funds tracked by Wall St. Rank held Balchem Corp as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.